Loss of logistics capacity and surgical opportunities due to natural disasters and infectious disease outbreaks
First written in FY2020. 8 of 9 entries say "Restated". Latest entry: FY2025-H1.
The whole theme swung hardest in 2020: 15 of 22 companies on the "Worse" side.
11 other companies' latest entry also says "Restated".
- FY2025-H1RestatedAnnual report
「During the interim consolidated accounting period under review, there were no significant changes in the matters described in this interim report regarding the business and accounting conditions that could materially affect investors’ decisions, or in the “Business and Other Risks” described in the securities report for the previous fiscal year.」
The company states that there have been no material changes in the risks of losing logistics and surgical opportunities due to natural disasters and the spread of infectious diseases. - FY2024RestatedAnnual report
「Our group is formulating and reviewing its business continuity plan (BCP plan) and taking measures to enable it to act promptly when such natural disasters or other events occur.」
The company continues to disclose the risks of natural disasters affecting logistics networks and infectious diseases causing treatment and surgery to be postponed, and identifies the formulation and review of its BCP plan as countermeasures. - FY2024-Q2RestatedAnnual report
「During the cumulative second quarter under review, there were no significant changes in the matters described in this quarterly report regarding the business and accounting conditions that could materially affect investors’ decisions, or in the “Business and Other Risks” described in the securities report for the previous fiscal year.」
The company states that there have been no material changes in the risks of losing logistics and surgical opportunities due to natural disasters and the spread of infectious diseases. - FY2024-Q1RestatedAnnual report
「During the first quarter of the current consolidated cumulative period, there were no occurrences of matters that could materially affect investors’ investment decisions among the matters relating to the business and financial position described in this quarterly report, nor were there any material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
The company states that there have been no material changes in the risks of losing logistics and surgical opportunities due to natural disasters and the spread of infectious diseases. - FY2023-Q2RestatedAnnual report
「During the cumulative second quarter under review, there were no significant changes in the matters described in this quarterly report regarding the business and accounting conditions that could materially affect investors’ decisions, or in the “Business and Other Risks” described in the securities report for the previous fiscal year.」
The company states that there have been no material changes in the risks of losing logistics and surgical opportunities due to natural disasters and the spread of infectious diseases. - FY2023-Q1RestatedAnnual report
「During the first quarter of the current consolidated cumulative period, there were no occurrences of matters that could materially affect investors’ investment decisions among the matters relating to the business and financial position described in this quarterly report, nor were there any material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
The company states that there have been no material changes in the risks of losing logistics and surgical opportunities due to natural disasters and the spread of infectious diseases. - FY2022-Q3RestatedAnnual report
「During the cumulative third quarter under review, there were no significant changes in the matters described in this quarterly report regarding the business and accounting conditions that could materially affect investors’ decisions, or in the “Business and Other Risks” described in the securities report for the previous fiscal year.」
The company states that there have been no material changes in the risks of losing logistics and surgical opportunities due to natural disasters and the spread of infectious diseases. - FY2022-Q1RestatedAnnual report
「During the first quarter of the current consolidated cumulative period, there were no occurrences of matters that could materially affect investors’ investment decisions among the matters relating to the business and financial position described in this quarterly report, nor were there any material changes to the “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
The company states that there have been no material changes in the risks of losing logistics and surgical opportunities due to natural disasters and the spread of infectious diseases. - FY2020First statedAnnual report
「Large-scale earthquakes, wind and flood damage, and other natural disasters could affect the Group's performance by disrupting logistics networks across Japan. In addition, if medical institutions respond to the spread of an infectious disease by postponing or delaying non-urgent treatment and surgery, sales opportunities for medical equipment and other products expected to be used in such treatment and surgery could be lost, affecting the Group's performance.」
The company comprehensively discloses the risks to business performance posed by the impact of natural disasters on logistics networks and the cancellation or postponement of treatment and surgery due to the spread of infectious diseases. It also describes the formulation and review of its BCP plan.